» Articles » PMID: 33168042

Improvements Needed to Support People Living and Working with a Rare Disease in Northern Ireland: Current Rare Disease Support Perceived As Inadequate

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2020 Nov 10
PMID 33168042
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many people living and working with rare diseases describe consistent difficulties accessing appropriate information and support. In this study an evaluation of the awareness of rare diseases, alongside related information and educational resources available for patients, their families and healthcare professionals, was conducted in 2018-2019 using an online survey and semi-structured interviews with rare disease collaborative groups (charities, voluntary and community groups) active across Northern Ireland (NI).

Methods: This study had 2 stages. Stage 1 was an online survey and stage 2 involved semi-structured interviews both with rare disease collaborative groups in Northern Ireland. The surveys and interviews were used to locate existing resources as well as identify gaps where the development of further resources would be appropriate.

Results: Ninety-nine rare disease collaborative groups engaged with the survey with 31 providing detailed answers. Resources such as information, communication, 'registries', online services, training and improvements to support services were queried. Excellent communication is an important factor in delivering good rare disease support. Training for health professionals was also highlighted as an essential element of improving support for those with a rare disease to ensure they approach people with these unique and challenging diseases in an appropriate way. Carers were mentioned several times throughout the study; it is often felt they are overlooked in rare disease research and more support should be in place for them. Current care/support for those with a rare disease was highlighted as inadequate. Nine semi-structured interviews were conducted with rare disease collaborative groups. Reoccurring themes included a need for more effective information and communication, training for health professionals, online presence, support for carers, and involvement in research.

Conclusions: All rare disease collaborative groups agreed that current services for people living and working with a rare disease are not adequate. An important finding to consider in future research within the rare disease field is the inclusion of carers perceptions and experiences in studies. This research provides insight into the support available for rare diseases across Northern Ireland, highlights unmet needs, and suggests approaches to improve rare disease support.

Citing Articles

Integrated Care for People Living With Rare Disease: A Scoping Review on Primary Care Models in Organization for Economic Cooperation and Development Countries.

Vidic N, McGlynn A, Abdi F, Tam C, Crampton R, Lim K J Prim Care Community Health. 2025; 16:21501319241311567.

PMID: 39772949 PMC: 11707790. DOI: 10.1177/21501319241311567.


The impact of COVID-19 pandemic on dermatology patients with rare skin diseases.

Vargu M, Dedej S, Vasili E Dermatol Reports. 2024; 16(4):9879.

PMID: 39669880 PMC: 11632452. DOI: 10.4081/dr.2024.9879.


Beliefs, screening attitudes and breast cancer awareness of young women with neurofibromatosis type 1: A reflexive thematic analysis.

Plunkett C, Pilkington M J Health Psychol. 2024; 30(3):369-383.

PMID: 38859614 PMC: 11894900. DOI: 10.1177/13591053241255053.


Exploring the support needs of Australian parents of young children with Usher syndrome: a qualitative thematic analysis.

Johansen L, OHare F, Shepard E, Ayton L, Pelentsov L, Kearns L Orphanet J Rare Dis. 2024; 19(1):129.

PMID: 38515174 PMC: 10956185. DOI: 10.1186/s13023-024-03125-w.


Factors affecting overall care experience for people living with rare conditions in the UK: exploratory analysis of a quantitative patient experience survey.

Jones J, Cruddas M, Simpson A, Meade N, Pushparajah D, Peter M Orphanet J Rare Dis. 2024; 19(1):77.

PMID: 38373961 PMC: 10877794. DOI: 10.1186/s13023-024-03081-5.


References
1.
Badiu C, Bonomi M, Borshchevsky I, Cools M, Craen M, Ghervan C . Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism. Orphanet J Rare Dis. 2017; 12(1):57. PMC: 5359990. DOI: 10.1186/s13023-017-0608-2. View

2.
Lasker J, Sogolow E, Sharim R . The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist. J Med Internet Res. 2005; 7(1):e10. PMC: 1550634. DOI: 10.2196/jmir.7.1.e10. View

3.
Forsythe L, Szydlowski V, Murad M, Ip S, Wang Z, Elraiyah T . A systematic review of approaches for engaging patients for research on rare diseases. J Gen Intern Med. 2014; 29 Suppl 3:S788-800. PMC: 4124116. DOI: 10.1007/s11606-014-2895-9. View

4.
Taruscio D, Arriola L, Baldi F, Barisic I, Bermejo-Sanchez E, Bianchi F . European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans. Public Health Genomics. 2014; 17(2):115-23. DOI: 10.1159/000360602. View

5.
Dharssi S, Wong-Rieger D, Harold M, Terry S . Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis. 2017; 12(1):63. PMC: 5374691. DOI: 10.1186/s13023-017-0618-0. View